Clinical Trial Update: Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy (sIFN-pred2)

View source ↗

Summary

This clinical trial update investigates whether early declines in hepatitis C virus levels can predict the outcome of interferon therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Disease

Drugs mentioned

• Interferon alfa-2a (interferon alfa-2a)
• Interferon alfa-2b (interferon alfa-2b)

Snippet

Sponsor: Junqi Niu | Conditions: Hepatitis C, Chronic, Liver Diseases | Status: UNKNOWN